ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest

Facility to Offer Higher Levels of Service for Patients and Physicians

Labcorp (NYSE: LH), a leading global life sciences company, today announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005470/en/

Photo courtesy of Labcorp

Photo courtesy of Labcorp

The approximately 25,000-square-foot facility features expanded capabilities and new equipment for performing high-quality and efficient testing—creating more robust lab offerings for the community. The laboratory, which currently employs 100 individuals, will include STAT testing to expedite results for high-priority tests.

“This new lab offers increased capabilities for microbiology testing, allowing for a more flexible test menu that is tailored to fit the needs of our providers,” said Amy Rhine-Pallas, senior vice president of Labcorp’s North Central Division. “Ultimately, this leads to better patient diagnoses and outcomes. Our goal is to continue to invest in and provide the highest-quality service to patients and health care providers across the Midwest.”

Labcorp acquired the diagnostic clinical laboratory testing business of South Bend Medical Foundation in October 2019, considerably enhancing the scope of local services Labcorp offers to hospitals, physicians and patients across parts of Indiana, Michigan, Ohio and Illinois. The new laboratory further expands services to include northwestern Indiana and southern Michigan, and provides the communities in these areas with increased access and more efficient diagnostic testing solutions. In addition, the laboratory underscores Labcorp’s commitment to Indiana and builds on its strong operating presence in the state, which includes Labcorp Drug Development’s central laboratory and other facilities in Indianapolis. Labcorp currently has a number of open positions at the South Bend facility. To apply for one of these jobs, please visit: http://www.labcorp.com/careers.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.